
New Product Introduction (NPI)
G&H accelerates new product introduction (NPI) for medical devices and life-science instruments - bridging design and manufacturing through validation, risk management, and process excellence.


Before any new medical device enters production, G&H conducts a series of Pre-Manufacturing Checks to verify that the design, documentation, and processes are ready for controlled manufacture.
This stage bridges product development and new product introduction (NPI), confirming that your device can be integrated seamlessly into our ISO 13485- and FDA 21 CFR 820-compliant quality system.
Our New Product Introduction (NPI) team lead a structured Design Master Record (DMR) and manufacturing gap analysis, reviewing the supplied technical documentation against G&H’s Quality Management System and regulatory requirements. During this activity, we:
This early diligence ensures your device transitions into manufacturing efficiently, minimizing risks of non-conformance or delays later in the process.
Every gap or risk identified is documented, reviewed with the customer, and resolved before the next NPI phase begins.
By verifying every element before manufacturing begins, G&H ensures your device is built on a foundation of precision, compliance, and confidence.